Subscribe: What's New: Vaccines, Blood & Biologics RSS Feed
http://www.fda.gov/cber/rss/whatsnewsrss.xml
Preview: What's New: Vaccines, Blood & Biologics RSS Feed

What's New: Vaccines, Blood & Biologics RSS Feed



Documents recently posted on the CBER Web Site



Last Build Date: Tue, 17 Feb 2009 11:38:00 -0500

 



BabyBIG

Tue, 08 Aug 2017 14:56:00 -0400




Exceptions and Alternative Procedures Approved Under 21 CFR 640.120

Fri, 28 Jul 2017 09:26:00 -0400

Title 21 Code of Federal Regulations 640.120(a) - The Director, Center for Biologics Evaluation and Research, may approve an exception or alternative procedures to any requirement in subchapter F (Biologics) of Chapter I (Parts 600 - 680) of title 21 of the Code of Federal Regulations regarding blood, blood components or blood products. Both licensed and unlicensed blood establishments must submit requests for an exception or alternative procedure to the requirements in Parts 600-680.